✦ LIBER ✦

CYP2D6 Genotype as a Marker for Benefit of Adjuvant Tamoxifen in Postmenopausal Women: Lessons Learned

✍ Scribed by Kelly, C. M.; Pritchard, K. I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CYP2D6 genotype in relation to tamoxifen

✍ Dezentjé, V. O.; Schaik, R. H. N.; Vletter-Bogaartz, J. M.; Straaten, T.; Wessel 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 459 KB

CYP2D6 genotype in relation to hot flash

✍ Dezentjé, Vincent O.; Gelderblom, Hans; Schaik, Ron H. N.; Vletter-Bogaartz, Jud 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 370 KB

CYP2D6 genotypes, endoxifen levels, and

✍ Richard R Love, Zuerenesay Desta, David Flockhart, Todd Skaar… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 167 KB

Genetic polymorphism of CYP2D6: a critic

✍ M. Debled; V. Le Morvan; A. Laurand; G. MacGrogan; V. Brouste; J. Robert; L. Mau 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

CYP2D6 Genotyping as an alternative to p

✍ McElroy, Suzin ;Richmond, Jodi ;Lira, Maruja ;Friedman, David ;Silber, B. Michae 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 399 KB

Cost-effectiveness analysis of anastrozo

✍ Gershon Y. Locker; Robert Mansel; David Cella; Deborah Dobrez; Sonja Sorensen; S 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB